IE44824L - Isolation of a placenta-specific glycoprotein. - Google Patents

Isolation of a placenta-specific glycoprotein.

Info

Publication number
IE44824L
IE44824L IE770787A IE78777A IE44824L IE 44824 L IE44824 L IE 44824L IE 770787 A IE770787 A IE 770787A IE 78777 A IE78777 A IE 78777A IE 44824 L IE44824 L IE 44824L
Authority
IE
Ireland
Prior art keywords
placenta
support
isolation
bound
order
Prior art date
Application number
IE770787A
Other versions
IE44824B1 (en
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of IE44824L publication Critical patent/IE44824L/en
Publication of IE44824B1 publication Critical patent/IE44824B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

In order to concentrate the placenta-specific protein PP5, a PP5-containing protein solution is brought into contact, at a pH of between 4 and 9, with an antibody against PP5 which is bound to an insoluble support. The support with the PP5 bound to it is separated off from the liquid phase. In order to release the PP5, this support is treated with an aqueous medium of a pH of from 2 to 4, or with a solution of a substance which dissociates protein bonds at a pH of from 4 to 9. The PP5 which is obtained can be used in a diagnostic agent for detecting PP5 and antibodies directed against PP5. [GB1555197A]
IE787/77A 1976-04-17 1977-04-15 Process for the isolation of a placenta-specific glycoprotein IE44824B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2616984A DE2616984C3 (en) 1976-04-17 1976-04-17 Method for the isolation and purification of a placenta-specific glycoprotein

Publications (2)

Publication Number Publication Date
IE44824L true IE44824L (en) 1977-10-17
IE44824B1 IE44824B1 (en) 1982-04-07

Family

ID=5975638

Family Applications (1)

Application Number Title Priority Date Filing Date
IE787/77A IE44824B1 (en) 1976-04-17 1977-04-15 Process for the isolation of a placenta-specific glycoprotein

Country Status (20)

Country Link
JP (1) JPS52154509A (en)
AT (1) AT362057B (en)
AU (1) AU517434B2 (en)
BE (1) BE853711A (en)
CA (1) CA1101847A (en)
CH (2) CH630643A5 (en)
DE (1) DE2616984C3 (en)
DK (1) DK168577A (en)
ES (2) ES457714A1 (en)
FI (1) FI60875C (en)
FR (1) FR2348222A1 (en)
GB (1) GB1555197A (en)
IE (1) IE44824B1 (en)
IL (1) IL51883A (en)
IT (1) IT1075832B (en)
LU (1) LU77143A1 (en)
NL (1) NL7703963A (en)
NO (1) NO146747C (en)
NZ (1) NZ183878A (en)
SE (1) SE7704359L (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2640387C3 (en) * 1976-09-08 1981-01-22 Behringwerke Ag, 3550 Marburg Tissue-specific protein and method for its production
DE2720704C2 (en) * 1977-05-07 1986-09-25 Behringwerke Ag, 3550 Marburg New glycoprotein, process for its production and its uses
DE2745680A1 (en) 1977-10-11 1979-04-12 Behringwerke Ag CONTRACEPTIVE MEANS
EP0029893B1 (en) * 1979-11-02 1987-05-20 Karl Prof. Dr. Theurer Process for concentration of tumor-inhibiting substances
DE3013724A1 (en) 1980-04-10 1981-10-15 Behringwerke Ag, 3550 Marburg NEW PROTEIN PP (DOWN ARROW) 9 (DOWN ARROW), METHOD FOR ITS ENRICHMENT AND PRODUCTION AND ITS USE
DE3334405A1 (en) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg MEMBRANE ASSOCIATED PROTEINS (MP (DOWN ARROW) 2 (DOWN ARROW)), METHOD FOR THEIR EXTRACTION AND USE
NZ212523A (en) * 1985-06-24 1989-01-06 Univ Massey Mobile phase for purification of proteins by high performance liquid chromatography
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms

Also Published As

Publication number Publication date
DE2616984C3 (en) 1981-10-29
FI60875B (en) 1981-12-31
NO771316L (en) 1977-10-18
CH630643A5 (en) 1982-06-30
IT1075832B (en) 1985-04-22
FI60875C (en) 1982-04-13
CH632091A5 (en) 1982-09-15
SE7704359L (en) 1977-10-18
IL51883A (en) 1980-02-29
AT362057B (en) 1981-04-27
DK168577A (en) 1977-10-18
DE2616984A1 (en) 1977-10-20
AU517434B2 (en) 1981-07-30
NZ183878A (en) 1980-04-28
DE2616984B2 (en) 1981-01-29
NL7703963A (en) 1977-10-19
ES457714A1 (en) 1978-02-16
FR2348222B1 (en) 1980-02-08
FI771186A7 (en) 1977-10-18
JPS52154509A (en) 1977-12-22
ES462699A1 (en) 1978-07-01
GB1555197A (en) 1979-11-07
BE853711A (en) 1977-10-18
AU2431977A (en) 1978-10-19
CA1101847A (en) 1981-05-26
FR2348222A1 (en) 1977-11-10
NO146747B (en) 1982-08-23
NO146747C (en) 1982-12-01
IE44824B1 (en) 1982-04-07
ATA266377A (en) 1980-09-15
IL51883A0 (en) 1977-06-30
LU77143A1 (en) 1977-11-14

Similar Documents

Publication Publication Date Title
Ternynck et al. A new method using p-benzoquinone for coupling antigens and antibodies to marker substances
AU8866291A (en) Assay for glycated blood proteins
AU607088B2 (en) Process for immobilising a protein on a solid phase
AU3090889A (en) Method for determination of a polyvalent substance using an immunoaggregate
EP0376133A3 (en) Method and device for measuring a target substance in a liquid sample
Lauf Antigen-antibody reactions and cation transport in biomembranes: immunophysiological aspects
EP0247730A3 (en) Antibodies, their preparation and use and products containing them
GB1555197A (en) Process for the isolation of a placentaspecificglycoprotein
ATE69891T1 (en) MONOCLONAL ANTIBODY DRAFT FOR DIAGNOSTIC USE.
CA2193323A1 (en) Process for preparing a synthetic calibrator for use in sandwich immunoassays, which calibrator consists of an antibody against one of the antibodies used in the assay and of a sequence of the analyte
AU567747B2 (en) Early detection of mammalian pregnancy
KR870005649A (en) Solidified antibody and preparation method
NO881904L (en) PROCEDURE FOR SELECTIVE IMMUNOLOGICAL DETERMINATION OF INTACT PROCOLLAGEN PEPTID (TYPE III) AND PROCOLLAGEN (TYPE III) IN BODY LIQUID, AND AGENT FOR ITS IMPLEMENTATION.
Stevens et al. Immunochemical and electrophoretic properties of oestrous rabbit uterine fluid proteins obtained by uterine ligation
EP0368273A3 (en) New method of assay for antigen
Yacobi et al. Intersubject variation of warfarin binding to protein in serum of normal subjects
ATE124706T1 (en) METHOD FOR ISOLATION OF BASAL MEMBRANE PROTEINS FROM HUMAN AND ANIMAL TISSUES.
ES482215A1 (en) Stabilized platelet factor 4 immunoassay standards and radio-immunoassay method.
EP0324603A3 (en) Improved solid phase enzyme immunoassay test apparatus and process for detection antibodies
GB1151608A (en) A Method for Determining Vitamin B12
IE780801L (en) Leucine-rich 3,1-5-ó(2) -glycoprotein and process for its¹isolation¹¹isolation
AU7059187A (en) Method for the detection of pregnancy disorders
AU3188089A (en) Method for detecting antibodies in blood, and membrane strip and membrane battery for use when carrying out the method
DE3477516D1 (en) Method and reagent for the direct detection of an analyte after the specific elimination of colloidal particles in aqueous solutions of biological origin
ES446939A1 (en) Process for the enrichment of pregnancy specific -glycoprrotein